Home   About Us  Email Us

Search:

Technology Translation

   Roadmapping
   Collaborative R&D
   Funding
   Case Studies

Case Studies index

 

 
 

Technology Translation - NuTaP: Collaborative R&D brings New Technology to Urinary Incontinence

The Problem
Urinary incontinence is a growing problem throughout the developed world as life expectancy rises. Within the UK alone, the Royal College of Physicians estimates that some 3 million people are affected, at an annual cost to the NHS of £500 million.

Of particular concern are cases of intractable incontinence where the only available treatment is long-term catheterisation. Catheter design has changed little since its introduction in 1937, and patient suffering and medical costs are high. A multi-disciplinary approach combining experience from the pirvate and public sectors is required to address the problem.

The Consortium
BHRSolutions' experience in multi-partner projects has been used to help put together a consortium of healthcare, academic and commercial bodies to research the potential of new technologies, in
a Foresight LINK project. These include Biocompatibles, Ranier Technologies, ETB, Mediplus, MCE, Limbs and Things, Ellis Developments and BHRSolutions, along with Durham and Cardiff Universities and the North Bristol NHS Trust.

BHRSolutions' is providing the 'New Urological Technologies and Products' (NuTaP) consortium with its experience in product development and in translating market needs into research and development plans. Consultancy in fluid mechanics will also be available as required.

The Approach
Catheter design for long-term catheterisation has changed little since its introduction in 1937 and suffers from two inherent problems

  • Susceptibility to colonisation by microbes such as Proteus Mirabilis, leading to the precipitation of phosphatic salts, stone formation and blockage
  • Rather than mimic the natural process of intermittent, complete emptying of the bladder, continuous drainage is provided

Both problems will be addressed by the project. A biomaterial will be developed to coat the catheter and resist colonisation and encrustation, while at the same time a microsystem will control the filling and emptying cycle. If successful, patient care will be improved and NHS costs reduced.

 


Proteus Mirabilis


Catheter Encrustation


Clean Catheter

To find out more, or for more information on using our technology Translation services in your industry, contact us.

    © Copyright BHR Group Limited 2003. All rights reserved.
Comments on our website? Contact our Webmaster.